sP-selectin levels associated with site of cancer
| Site of cancer . | sP-selectin level, ng/mL [median (IQR)] . |
|---|---|
| Breast (n = 125) | 40.9 (32.5-49.5) |
| Lung (n = 86) | 43.9 (35.5-55.5) |
| Upper gastrointestinal (n = 30) | 44.9 (40.0-59.5) |
| Colorectal (n = 100) | 43.2 (32.7-52.8) |
| Pancreas (n = 42) | 40.2 (32.7-52.4) |
| Kidney (n = 19) | 44.6 (35.3-58.6) |
| Prostate (n = 72) | 45.2 (35.9-53.3) |
| Brain (n = 80) | 41.1 (32.2-55.3) |
| Lymphoma (n = 73) | 40.6 (31.2-53.9) |
| Multiple myeloma (n = 18) | 33.3 (27.2-50.7) |
| Others (n = 42) | 41.3 (34.1-58.0) |
| P | .25* |
| Site of cancer . | sP-selectin level, ng/mL [median (IQR)] . |
|---|---|
| Breast (n = 125) | 40.9 (32.5-49.5) |
| Lung (n = 86) | 43.9 (35.5-55.5) |
| Upper gastrointestinal (n = 30) | 44.9 (40.0-59.5) |
| Colorectal (n = 100) | 43.2 (32.7-52.8) |
| Pancreas (n = 42) | 40.2 (32.7-52.4) |
| Kidney (n = 19) | 44.6 (35.3-58.6) |
| Prostate (n = 72) | 45.2 (35.9-53.3) |
| Brain (n = 80) | 41.1 (32.2-55.3) |
| Lymphoma (n = 73) | 40.6 (31.2-53.9) |
| Multiple myeloma (n = 18) | 33.3 (27.2-50.7) |
| Others (n = 42) | 41.3 (34.1-58.0) |
| P | .25* |
P value in Kruskal-Wallis test for association of sP-selectin levels and the site of cancer in the total study population.